Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab.

ABSTRACT:

SUBMITTER: Felten R 

PROVIDER: S-EPMC8575482 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature